In addition, molecular studies have supported stepwise carcinogenesis of the gallbladder through BilIN, including the involvement of TP53 and KRAS mutations in BilIN and dysregulation of p16/cyclin-D1/CDK4 cell cycle pathway in both BilIN and gallbladder cancer [41,42]. This evidence concerns the gene KRAS and gallbladder cancer.